About usSign in
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
  • Tel Aviv
  • Isreal
Investment stages
  • Pre-Seed
  • Seed
  • Series A
  • Series B
  • Series C
Industries
  • Pharmaceuticals
  • Healthcare
  • Medical Devices
  • Digital Health
  • Life Sciences
About
ATP, Founded in 1999, is a life sciences venture capital firm with $2.9 billion in committed capital. They have offices in New York, South San Francisco, and Cambridge, MA. ATP specializes in translating emerging scientific advances into innovative treatments and creating companies at various stages of development.
Min check size
$10M
Max check size
$25M
Fund size
NPS

Investment Thesis

ATP focuses on creating and investing in transformative biotechnology companies. They provide flexible capital, strategic insight, and operational resources to build sustainable, researchdriven enterprises. ATP invests in companies from preIP ideas to asset spinouts and supports them from Seed stage through IPO and beyond.
Lead investor
Co Invest
Number of exits
Preferred contact method

Team

Seth Harrison – Founder and Managing Partner

William Engels – Chief Financial Officer

Daniel Finkelman – General Counsel

Sally Jacob – Head of Communications

Matthew P. Jacobson – Venture Partner

Paul Da Silva Jardine – Venture Partner

Neena Kadaba – Entrepreneur in Residence

Portfolio

Aulos Bioscience

Braeburn

Chinook Therapeutics

Coelacanth

Corvidia Therapeutics

Cyrano Sciences

Deep Apple Therapeutics

Evercrisp Biosciences

Galvanize Therapeutics

Gloucester Pharma

HeartWare International

Initial Therapeutics

Marengo Therapeutics

Marlinspike Therapeutics

Nereid Therapeutics

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp